PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies (Q42623661)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 November 2011

Language	Label	Description	Also known as
English	PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies	scientific article published on 3 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies (English)

1 reference

Europe PubMed Central

3 November 2017

Jean-Baptiste Demoulin

26

1 reference

Europe PubMed Central

3 November 2017

12

object named as

Frank Speleman

1 reference

Europe PubMed Central

3 November 2017

16

object named as

Nathalie Auger

1 reference

Europe PubMed Central

3 November 2017

author name string

Francois P Duhoux

1

1 reference

Europe PubMed Central

3 November 2017

Geneviève Ameye

2

1 reference

Europe PubMed Central

3 November 2017

Carmen P Montano-Almendras

3

1 reference

Europe PubMed Central

3 November 2017

Khadija Bahloula

4

1 reference

Europe PubMed Central

3 November 2017

Marie J Mozziconacci

5

1 reference

Europe PubMed Central

3 November 2017

Sophy Laibe

6

1 reference

Europe PubMed Central

3 November 2017

Iwona Wlodarska

7

1 reference

Europe PubMed Central

3 November 2017

Lucienne Michaux

8

1 reference

Europe PubMed Central

3 November 2017

Pascaline Talmant

9

1 reference

Europe PubMed Central

3 November 2017

Steven Richebourg

10

1 reference

Europe PubMed Central

3 November 2017

Eric Lippert

11

1 reference

Europe PubMed Central

3 November 2017

Christian Herens

13

1 reference

Europe PubMed Central

3 November 2017

Stéphanie Struski

14

1 reference

Europe PubMed Central

3 November 2017

Sophie Raynaud

15

1 reference

Europe PubMed Central

3 November 2017

Nathalie Nadal

17

1 reference

Europe PubMed Central

3 November 2017

Katrina Rack

18

1 reference

Europe PubMed Central

3 November 2017

Francine Mugneret

19

1 reference

Europe PubMed Central

3 November 2017

Isabelle Tigaud

20

1 reference

Europe PubMed Central

3 November 2017

Marina Lafage

21

1 reference

Europe PubMed Central

3 November 2017

Sylvie Taviaux

22

1 reference

Europe PubMed Central

3 November 2017

Catherine Roche-Lestienne

23

1 reference

Europe PubMed Central

3 November 2017

Dominique Latinne

24

1 reference

Europe PubMed Central

3 November 2017

Jeanne M Libouton

25

1 reference

Europe PubMed Central

3 November 2017

Hélène A Poirel

27

1 reference

Europe PubMed Central

3 November 2017

Groupe Francophone de Cytogénétique Hématologique (GFCH)

28

1 reference

Europe PubMed Central

3 November 2017

Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO)

29

1 reference

Europe PubMed Central

3 November 2017

language of work or name

0 references

publication date

3 November 2011

1 reference

Europe PubMed Central

3 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

3 November 2017

156

1 reference

Europe PubMed Central

3 November 2017

1

1 reference

Europe PubMed Central

3 November 2017

76-88

1 reference

Europe PubMed Central

3 November 2017

Prdm16 is a physiologic regulator of hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Low expression of MDS1-EVI1–like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Prdm16 is required for normal palatogenesis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

ETV6: a versatile player in leukemogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Structural origins for the product specificity of SET domain protein methyltransferases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

PRDM16 expression in the developing mouse embryo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

The role of Rho GTPases and SNAREs in mediator release from granulocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Unsafe SETs: histone lysine methyltransferases and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

PRDM16 controls a brown fat/skeletal muscle switch

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Dissecting the N-ethylmaleimide-sensitive factor: required elements of the N and D1 domains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Upregulation of MEL1 and FLJ42875 genes by position effect resulting from a t(1;2)(p36;p21) occurring during evolution of chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08918.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2011.08918.X

1 reference

Europe PubMed Central

3 November 2017

release_2tssaex2cfdwpk57qi3ow3vt4y

1 reference

https://api.fatcat.wiki/v0/release/2tssaex2cfdwpk57qi3ow3vt4y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42623661&oldid=1963318563"